Clinical Trial Update: Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) [Phase 3]

View source ↗

Summary

Phase 3 trial update for the SAPPHIRE study evaluating carotid stenting with embolic protection in high-risk patients has completed. The sponsor is Cordis and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Disease

Drugs mentioned

• Carotid stent with embolic protection device

Snippet

Sponsor: Cordis US Corp. | Conditions: Carotid Artery Disease | Phase 3 | Status: COMPLETED